Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: Discrepancies using different monoclonal antibody clones

Leukemia and Lymphoma

Volumn 42, Issue 1-2, 2001, Pages 75-82

  Firat, H ^a   Favier, R ^a   Adam, M ^a   Leverger, G ^a   Landman Parker, J ^a   Cayre, Y ^a   Douay, L ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Acute lymphoblastic leukaemia; Childhood; Flow cytometry; Myeloid antigens; t(12, 21)

Indexed keywords

BIOLOGICAL MARKER; CD33 ANTIGEN; CELL ANTIGEN; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G1; MEMBRANE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; MYELOID ANTIGEN; PHYCOERYTHRIN; RHODAMINE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; BONE MARROW CELL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 21; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LABORATORY DIAGNOSIS; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MOLECULAR CLONING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STAINING; TREATMENT PLANNING;

EID: 0034915136     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097678     Document Type: Article

References (21)

1. Acute mixed lineage leukemia: Clinicopathologic correlations and prognostic significance
2. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia
3. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy
4. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia
5. Myeloid surface antigen expression in adult acute lymphoblastic leukemia
6. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): Immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics
7. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia
8. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia
9. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood
10. Co-expression of myeloid antigens in childhood acute lymphoblastic leukemia: Relationship with the stage of differentiation and clinical significance
11. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: A report from the Children's Cancer Group
12. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies
13. The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukemias express TEL-AML1 fusion transcripts
14. The morphological classification of acute lymphoblastic leukemia: Concordance among observers and clinical correlations
15. Use of immunophenotype as part of the prognostic stratification for childhood ALL in the FRALLE 93 protocol
16. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia
17. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukemia patients: Diagnostic and prognostic implications
18. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: An analysis of a prospective trial including 562 tested patients (LALA87) French
19. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia
20. 14q32 translocations are associated with mixed-lineage expression in childhood acute leukemia
21. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials